2024-03-28T09:04:56Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_2DE4BF247500
2024-03-23T02:06:14Z
serval:BIB_2DE4BF247500
Exercise aggravates cardiovascular risks and mortality in rats with disrupted nitric oxide pathway and treated with recombinant human erythropoietin.
10.1007/s00421-011-1829-z
000293980000039
21249387
Meziri
F.
author
Binda
D.
author
Touati
S.
author
Pellegrin
M.
author
Berthelot
A.
author
Touyz
R.M.
author
Laurant
P.
author
article
2011
European Journal of Applied Physiology
1439-6327
1439-6319
journal
111
8
1929-1938
Animals
Cardiovascular Diseases/etiology
Cardiovascular Diseases/mortality
Down-Regulation/drug effects
Enzyme Inhibitors/pharmacology
Erythropoietin/pharmacology
Humans
Male
Mortality
NG-Nitroarginine Methyl Ester/pharmacology
Nitric Oxide/antagonists & inhibitors
Nitric Oxide/metabolism
Nitric Oxide Synthase/antagonists & inhibitors
Nitric Oxide Synthase/metabolism
Physical Conditioning, Animal/physiology
Rats
Rats, Wistar
Recombinant Proteins/pharmacology
Risk Factors
Signal Transduction/drug effects
Signal Transduction/physiology
eng
60_published
Publication types: Evaluation Studies ; Journal ArticlePublication Status: ppublish
https://serval.unil.ch/notice/serval:BIB_2DE4BF247500
https://serval.unil.ch/resource/serval:BIB_2DE4BF247500.P001/REF.pdf
Restricted: indefinite embargo
Copying allowed only for non-profit organizations